Navigation Links
American Pacific Reports Fiscal 2013 Results; Provides Outlook For Fiscal 2014
Date:12/12/2013

th the revenue increases and additional production volume that will support Fiscal 2014 revenues.  Because a meaningful portion of our revenue volume for Fiscal 2014 was produced in Fiscal 2013, we expect that the operating margin benefit reflected by this increase in production volume in Fiscal 2013 will reverse in the following year and result in a decline in operating margin for this segment in Fiscal 2014.

For the Fiscal 2013 fourth quarter, revenues and operating profit increased compared to the Fiscal 2012 fourth quarter due to changes in inter-quarter timing.  The quarterly timing of revenues in any particular fiscal year is largely driven by our customers' delivery requirements.  In the Fiscal 2013 fourth quarter, the Specialty Chemicals segment shipped approximately 47% of its Fiscal 2013 perchlorate volume compared to 19% of Fiscal 2012 perchlorate volume shipped in the Fiscal 2012 fourth quarter.Corporate ExpensesCorporate operating expenses increased $2.8 million in Fiscal 2013 compared to Fiscal 2012. The most significant increase is an approximately $1.4 million increase (most of which occurred in the Fiscal 2013 fourth quarter) in accrued estimated compensation costs for long-term, share-based, incentive compensation, driven by the rapid rise in the Company's share price during the Fiscal 2013 fourth quarter.  Accounting for the issuance of restricted stock units requires that we revalue estimated compensation expense each quarter based on the closing share price of our common stock for the quarter.  The Company's common stock closed at $54.76 on September 30, 2013, resulting in a significant increase in estimated compensation expense from prior measurements. Actual compensation received by the grantees is contingent upon the achievement of a financial performance measure for the two years ending September 30, 2014 and will be valued based on the closing share price of our common stock on that date.  Accrued long-
'/>"/>

SOURCE American Pacific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
3. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
4. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
7. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
8. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
9. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
10. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
11. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical ... in opioid antagonists, announced today that it has ... respect to its naloxone-based opioid overdose reversal nasal ... received an additional commitment from the National Institute ... Institutes of Health ("NIH"), to fund a second ...
(Date:7/23/2014)... July 23, 2014 This September leading clinicians ... Las Vegas for DOCtalk 2014 ... author, forward thinker and private practitioner Dr. David ... to candidly discuss clinical and practice management efficiency and ... a unique opportunity to welcome fresh thinking and join ...
(Date:7/23/2014)... 23, 2014 Global healthcare company ... facing currency headwinds, increased price competition and supply disruptions ... Andrew Witty points out that the company is very ... reason to be confident about long-term prospects as well ... CFO Simon Dingemans adds that ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 32014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
(Date:7/23/2014)... 2014 A Forever Recovery, an open-ended ... to a great start and gives them a solid ... a new Internet Addiction section of its website at ... learn that Internet addiction is not just as legitimate ... that it’s trapping more and more victims each year ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Adipic ... which is mainly a high-performance plastic, often referred ... range of materials, depending on the monomers employed. ... the automotive industry and the increasing number of ... adipic acid market share, followed by Europe and ...
(Date:7/23/2014)... 23, 2014 (HealthDay News) -- Children and teens who lose ... death in adulthood, a new study suggests. People who ... 50 percent greater risk of death during the study period ... parent, according to the report. Although the study found ... risk of premature death, it wasn,t designed to prove cause-and-effect. ...
(Date:7/23/2014)... For critically ill patients arriving at the emergency ... sedation and amnesia for rapid, life-saving intubation, despite ... The results of a systematic review of ... regard as a "wonder drug" are published online ... The Effect of Ketamine on Intracranial and Cerebral ...
(Date:7/23/2014)... July 23, 2014 SafeUseNow? ... intervention program developed by Principled Strategies , ... HealthPlan of California . Utilizing SafeUseNow’s patent-pending risk ... risk of misusing and abusing controlled substance drugs, ... addiction among its members. , The agreement with ...
Breaking Medicine News(10 mins):Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4
... Ind., Nov. 21 Symmetry Medical Inc. (NYSE: SMA ... device industry and other medical markets, announced today that Brian S. ... Vice President and Chief Financial Officer, are scheduled to present at ... York Palace Hotel on Wednesday, December 3, 2008 at 12:30 p.m. ...
... smoking will receive big prizes during a special on-ice presentation ... Energy Center. The winners,were participants in The QuitCash Challenge, a ... The grand prize winner will ... cards from Gander Mountain. , ...
... study suggests , , FRIDAY, Nov. 21 (HealthDay News) -- The ... of asthma, new research suggests. , Babies born in autumn -- ... have almost a 30 percent increased risk of asthma compared to ... in the first December issue of the American Journal of ...
... Just three days after the,JUPITER trial results were presented ... by the New England Journal of Medicine, an,AlphaDetail survey ... anticipate a 14% increase in the use of drug ... risk patients. , ...
... travel nationwide to,ten top locations for Indoor Cycling / ... of innovative cycling training DVDs. The DVDs utilize,first-person ... selectable vocal coaching from industry experts. Sally Edwards,Ironman ... Matty Reed, US,triathlete champion and Olympian are just a ...
... Draeger Safety, Inc., located in,Pittsburgh PA, and ... products,provider, is countering what it believes are unsubstantiated ... of a patent,infringement on the popular Draeger PSS7000 ... Draeger has a ...
Cached Medicine News:Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:Autumn Babies More Prone to Asthma 2Health News:Autumn Babies More Prone to Asthma 3Health News:Physicians Anticipate Higher Prescribing Based on JUPITER Study 2Health News:Global Ride Tours Best 12 Cities for SPINNING(R) or Indoor Cycling 2Health News:Draeger Counters What It Believes Are Unsubstantiated Allegations of Patent Infringement by Sperian 2
2 mm wide x 3 mm long, with rounded triangular tip. Angled 45 degrees. Hexagonal handle....
5.5 pointed curved blade. Octagonal handle....
3 mm curved blade. Round handle....
8 mm downcutting Royce blade. Angled shaft. 60 mm from angle to tip....
Medicine Products: